Mu-Tzu Chu
Impact in
- Pharmacology top 5%
- Drug-Induced Adverse Reactions
- Rheumatology top 10%
- Urticaria and Related Conditions
- Eosinophilic Disorders and Syndromes
Papers in
-
- Drug-Induced Adverse Reactions 5
-
- Urticaria and Related Conditions 4
- Co-authors
- Wen‐Hung Chung (8 shared papers)Wen‐Hung Chung (6 shared papers)Ren‐You Pan (2 shared papers)Wan‐Chun Chang (3 shared papers)Wei-Chi Wang (1 shared paper)Chun‐Bing Chen (4 shared papers)Chuang‐Wei Wang (3 shared papers)Elizabeth J. Phillips (1 shared paper)
In The Last Decade
Mu-Tzu Chu
8 papers receiving 292 citations
Peers
Comparison fields: 5 of 56
- Pharmacology 191
- Rheumatology 114
- Toxicology 18
- Dermatology 36
- Pathology and Forensic Medicine 73
Countries citing papers authored by Mu-Tzu Chu
This map shows the geographic impact of Mu-Tzu Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu-Tzu Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu-Tzu Chu more than expected).
Fields of papers citing papers by Mu-Tzu Chu
This network shows the impact of papers produced by Mu-Tzu Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu-Tzu Chu. The network helps show where Mu-Tzu Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mu-Tzu Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 96 | |
| 2 | 2019 | 88 | |
| 3 | 2019 | 49 | |
| 4 | 2020 | 18 | |
| 5 | 2023 | 17 | |
| 6 | 2022 | 12 | |
| 7 | 2020 | 9 | |
| 8 | 2023 | 7 |
About Mu-Tzu Chu
Mu-Tzu Chu is a scholar working on Pharmacology, Rheumatology, Pathology and Forensic Medicine, Molecular Biology and Oncology, having authored 8 papers that have together received 296 indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (5 papers), Urticaria and Related Conditions (4 papers), Autoimmune Bullous Skin Diseases (3 papers), Immunotherapy and Immune Responses (2 papers), Pharmacovigilance and Adverse Drug Reactions (1 paper), CAR-T cell therapy research (1 paper), Contact Dermatitis and Allergies (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Pharmacology (191 citations), Rheumatology (114 citations), Toxicology (18 citations), Dermatology (36 citations) and Pathology and Forensic Medicine (73 citations). Mu-Tzu Chu has collaborated with scholars based in Taiwan, China and Australia. Frequent co-authors include Wen‐Hung Chung, Wen‐Hung Chung, Ren‐You Pan, Wan‐Chun Chang, Wei-Chi Wang, Chun‐Bing Chen, Chuang‐Wei Wang, Elizabeth J. Phillips, Yeong‐Jian Jan Wu and Jean‐Claude Roujeau. Their work appears in journals such as Journal of Investigative Dermatology, Pharmaceutics, Biomedicines, The American Journal of Chinese Medicine and Journal of the European Academy of Dermatology and Venereology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.